Anil Palepu

Anil Palepu

Auto-generated profile, based on publicly available information

Anil Palepu

Google Research, Mountain View, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in NEJM AI
Verified
Journal Article
Closed access
TTTao Tu
Tao Tu
SAShekoofeh Azizi
Shekoofeh Azizi
DDDanny Driess
Danny Driess
MSMike Schaekermann
Mike Schaekermann
MAMohamed Amin
Mohamed Amin
VNVivek Natarajan
Vivek Natarajan

19 May 2026 in Nature
Verified
Journal Article
Open access
JGJuraj Gottweis
Juraj Gottweis
WWWei-Hung Weng
Wei-Hung Weng
ADAlexander Daryin
Alexander Daryin
TTTao Tu
Tao Tu
PSPetar Sirkovic
Petar Sirkovic
VNVivek Natarajan
Vivek Natarajan
Scientific discovery is driven by scientists generating hypotheses for complex problems that undergo rigorous experimental validation. To augment this process, we introduce Co-Scientist, a multi-agent artificial intelligence (AI) system built on Gemini for structured scientific thinking and hypothesis generation. Co-Scientist aims to help scientists discover new original knowledge. Conditioned on their research objectives and previous scientific evidence, it formulates demonstrably novel research hypotheses for experimental verification. The system’s design involves agents continuously generating, critiquing and refining hypotheses accelerated by scaling test-time compute. Key contributions include (1) a multi-agent architecture with an asynchronous task execution framework for flexible compute scaling, and (2) a tournament evolution process for self-improving hypotheses generation. Automated evaluations show continued benefits of test-time compute scaling, improving hypothesis quality over time. Although this is a general-purpose system, we focus the validation in three biomedical applications: drug repurposing; novel-target discovery 1 ; and explaining mechanisms of antimicrobial resistance 2 . Specifically, Co-Scientist helped to identify new drug-repurposing candidates and synergistic combination therapies for acute myeloid leukaemia that were validated through in vitro experiments. These real-world validations demonstrate the potential of Co-Scientist to accelerate scientific discovery and usher in an era of AI-empowered scientists.

18 May 2023 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
DSDenys Shay
Denys Shay
BKBhawesh Kumar
Bhawesh Kumar
DBDavid Bellamy
David Bellamy
APAnil Palepu
Anil Palepu
MDMark Dershwitz
Mark Dershwitz
ABAndrew Beam
Andrew Beam

6 February 2026 in Nature Medicine
Verified
Journal Article
Open access
PDF file
JOJack W. O’SUllivan
Jack W. O’SUllivan
APAnil Palepu
Anil Palepu
KSKhaled Saab
Khaled Saab
WWWei-Hung Weng
Wei-Hung Weng
DADaniel Kwasi Amponsah
Daniel Kwasi Amponsah
TTTao Tu
Tao Tu
The scarcity of subspecialist medical expertise poses a considerable challenge for healthcare delivery. This issue is particularly acute in cardiology, where timely, accurate management determines outcomes. We explored the potential of Articulate Medical Intelligence Explorer (AMIE), a large language model-based experimental medical artificial intelligence system, to augment clinical decision-making in this challenging context. We conducted a randomized controlled trial comparing large language model-assisted care with the usual care of complex patients suspected of having a genetic cardiomyopathy, and we curated a real-world dataset of complex cases from a subspecialist cardiology practice. Nine participating general cardiologists were provided with access to both clinical text reports and raw diagnostic data—including electrocardiograms, echocardiograms, cardiac magnetic resonance imaging scans and cardiopulmonary exercise testing—and were randomized to manage these cases, either with or without assistance from AMIE. We developed a ten-domain evaluation rubric used by three blinded subspecialists to evaluate the quality of triage, diagnosis and management. In our randomized controlled trial with retrospective patient data, subspecialists favored large language model-assisted responses overall, and for the management plan and diagnostic testing domains, with the remaining domains considered a tie. Overall, subspecialists preferred AMIE-assisted cardiology assessments 46.7% of the time, compared with 32.7% for cardiologists alone ( P = 0.02), with 20.6% rated as a tie. Subspecialists also quantified errors, extra and missing content, reasoning and potential bias. Cardiologists alone had more clinically significant errors (24.3% versus 13.1%, P = 0.033) and more missing content (37.4% versus 17.8%, P = 0.0021) than cardiologists assisted by AMIE. Lastly, cardiologists who used AMIE reported that AMIE helped their assessment more than half the time (57.0%) and saved time in 50.5% of cases.

17 June 2026 in Nature
Verified
Journal Article
Open access
VLValentin Liévin
Valentin Liévin
APAnil Palepu
Anil Palepu
WWWei-Hung Weng
Wei-Hung Weng
KSKhaled Saab
Khaled Saab
DSDavid Stutz
David Stutz
MSMike Schaekermann
Mike Schaekermann
Although large language models have shown promise in diagnostic dialogue 1 , their capabilities for effective management reasoning, including disease progression, therapeutic response and safe medication prescription, have remained underexplored. We have advanced the previously demonstrated diagnostic capabilities of the Articulate Medical Intelligence Explorer (AMIE) 1–3 using a new large-language-model-based agentic system optimized for multivisit clinical management and dialogue. To ground the reasoning of AMIE in authoritative clinical knowledge, we leveraged the long-context capabilities of Gemini 4 , combining in-context retrieval with structured reasoning to align its output with up-to-date clinical practice guidelines and drug formularies. In a randomized, blinded virtual Objective Structured Clinical Examination study, AMIE was compared to 21 primary care physicians (PCPs) across 100 multivisit case scenarios designed to reflect the guidance of the UK National Institute for Health and Care Excellence and BMJ Best Practice guidelines. AMIE was non-inferior to PCPs in management reasoning, as assessed by specialists, and scored better both with respect to preciseness of treatment and investigation, and in terms of its alignment with and grounding in clinical guidelines. To benchmark medication reasoning, we developed RxQA, a multiple-choice question benchmark that was derived from two national drug formularies (from the USA and UK) and validated by board-certified pharmacists. Although AMIE and PCPs both benefited from the ability to access external drug information, AMIE outperformed PCPs on higher-difficulty questions. Although further research will be needed before real-world translation of AMIE, its strong performance across evaluations marks a significant step towards use of conversational artificial intelligence as a tool in disease management.

14 May 2026 in Nature Medicine
Verified
Journal Article
Open access
PDF file
KSKhaled Saab
Khaled Saab
CPChunjong Park
Chunjong Park
TSTim Strother
Tim Strother
JFJan Freyberg
Jan Freyberg
DBDavid G. T. Barrett
David G. T. Barrett
RTRyutaro Tanno
Ryutaro Tanno
Real-world clinical practice is inherently multimodal, relying on the synthesis of patient history with visual information such as medical imagery and clinical documents. Although large language models (LLMs) have shown promise in diagnostic dialogue, their evaluation has been largely restricted to text-only interactions, failing to capture the complexity of modern remote care delivery. Here we introduce a multimodal extension of the Articulate Medical Intelligence Explorer (multimodal AMIE), capable of gathering, interpreting and reasoning about multimodal data within a diagnostic conversation. To achieve this, we developed a state-aware dialogue framework that dynamically guides history-taking based on diagnostic uncertainty and evolving patient states, emulating the structured reasoning of experienced clinicians. We evaluated this updated, state-aware version of multimodal AMIE against primary care physicians (PCPs) in a randomized, blinded exploratory study comprising 105 simulated telehealth consultations, which included dermatology photographs, electrocardiograms and clinical documents. As assessed by 18 specialist physicians, multimodal AMIE outperformed PCPs not only in diagnostic accuracy but also in conversation quality, including history-taking and empathy. Specifically, multimodal AMIE demonstrated superior performance on 29 of 32 evaluation axes, including seven of nine metrics that assess multimodal reasoning. These results validate the efficacy of state-aware reasoning in bridging the gap between text and visual information and demonstrate the potential for artificial intelligence (AI) systems to augment clinicians in complex, multimodal diagnostic settings.